BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Okubo H, Ando H, Sorin Y, Nakadera E, Fukada H, Morishige J, Miyazaki A, Ikejima K. Gadoxetic acid-enhanced magnetic resonance imaging to predict paritaprevir-induced hyperbilirubinemia during treatment of hepatitis C. PLoS One 2018;13:e0196747. [PMID: 29709031 DOI: 10.1371/journal.pone.0196747] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Yuan X, Wang S, Shi W, Cai Y, Chen Y, Chen M, Peng Y, Ao G. Dual Plasma Sampling Method to Determine the Hepatic and Renal Clearance of the 2 Diastereoisomers of Gd-EOB-DTPA. Invest Radiol 2020;55:168-73. [PMID: 31917760 DOI: 10.1097/RLI.0000000000000622] [Reference Citation Analysis]
2 Wang YK, Lee WP, Wang YW, Huang YH, Hou MC, Chang YL, Lan KH. Precipitating factors causing hyperbilirubinemia during chronic hepatitis C treatment with paritaprevir/ritonavir/ombitasvir and dasabuvir. J Chin Med Assoc 2020;83:1071-8. [PMID: 33273269 DOI: 10.1097/JCMA.0000000000000429] [Reference Citation Analysis]
3 Fahlenkamp UL, Kunkel J, Ziegeler K, Neumann K, Adams LC, Engel G, Böker SM, Makowski MR. Correlation of Native Liver Parenchyma T1 and T2 Relaxation Times and Liver Synthetic Function Tests: A Pilot Study. Diagnostics (Basel) 2021;11:1125. [PMID: 34203008 DOI: 10.3390/diagnostics11061125] [Reference Citation Analysis]